Levels of Evidence Required to Determine the Benefit of Treating CCSVI to Alleviate Symptoms of MS- A neurology perspective.

“This is a keeper of an article - two MS specialists demonstrating their breathtaking ignorance of the underlying venous pathology of MS going back to Carswell's first illustration of MS spinal lesions... It is a masterclass of everything that is wrong in MS - the assumptions that MS is a primarily demyelinating condition; that T and B cells have anything to do with the formation of MS lesions... oh and dont forget the ULTIMATE GOLD STANDARD OF MS DIAGNOSIS practised by neurologists the world over:

IT IS NOT ANYTHING ELSE - so it must be..... MS....

Who could possibly trust any MS neurologist to design CCSVI trials based on 'types' of MS when NOT ONE of them appears to have any knowledge or rational explanation for Dawson finger lesion formations in the periventricular region in the brain - lesions orientated along the axis of the central veins which CHARACTERISE MS? They also have zero knowledge about the unique characteristics behind the formation of spinal MS lesions via physical tugging on the denticulate ligaments... They can offer no rationale for how their beloved T and B cells cause inverted venous blood flows to literally PUNCH holes in the tissue of our brains and spinal cord?

Put my life in the hands of a neurologist?

No chance"
Alison Fisher

http://bmctoday.net/evtoday/2012/07/article.asp?f=levels-of-evidence-required-to-alleviate-symptoms-of-ms-a-neurology-perspective


A neurology perspective.
bmctoday.net
Multiple sclerosis (MS) is a demyelinating disease of the central nervous system (CNS) with multiple and variable clinical courses and symptoms. MS affects women more than men, younger adults (20–50 years of age) more than children or elderly, Caucasians more than other races, people with the higher...